Relationship of cystatin-C change and the prevalence of death or dialysis need after acute kidney injury: A meta-analysis

Nephrology

Volumn 19, Issue 11, 2014, Pages 679-684

  Feng, Yunlin ^a   Zhang, Yue ^a   Li, Guisen ^a   Wang, Li ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Acute kidney injury; Cystatin C; Death; Dialysis; Meta analysis

Indexed keywords

CYSTATIN C; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ARTICLE; COCHRANE LIBRARY; DEATH; EMBASE; FOLLOW UP; HUMAN; MEDLINE; META ANALYSIS; RENAL REPLACEMENT THERAPY; SYSTEMATIC REVIEW; ACUTE KIDNEY INJURY; BLOOD; MORTALITY;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CYSTATIN C; HUMANS; RENAL DIALYSIS;

EID: 84907905223     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12312     Document Type: Article

References (16)

1. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit. Care 2004; 8: R204-R212.
2. Ronco C, Levin A, Warnock DG et al. Improving outcomes from acute kidney injury (AKI) : Report on an initiative. Int. J. Artif. Organs 2007; 30: 373-6.
3. Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (cystatin-C) amongst the cysteine proteinase inhibitors. Biochem. Biophys. Res. Commun. 1984; 120: 631-6.
4. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin-C compared to serum creatinine for the estimation of renal dysfunction in adults and children: A metaanalysis. Clin. Biochem. 2007; 40: 383-91.
5. Zhang Z, Lu B, Sheng X et al. Cystatin-C in prediction of acute kidney injury: A Systemic review and meta-analysis. Am. J. Kidney Dis. 2011; 58: 356-65.
6. Grades od Recommondation and Levels of Evidence. 2009 Available at http://www.cebm.net/index.aspx?o=1025.
7. Spahillari A, Parikh CR, Sint K et al. Serum cystatin-C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: A prospective cohort study. Am. J. Kidney Dis. 2012; 60: 922-9.
8. Li Y, Fu C, Zhou X et al. Urine interleukin-18 and cystatin-C as biomarkers of acute kidney injury in critically ill neonates. Pediatr. Nephrol. 2012; 27: 851-60.
9. Kwon SH, Hyun J, Jeon JS et al. Subtle change of cystatin-C, with or without acute kidney injury, associated with increased mortality in the intensive care unit. J. Crit. Care 2011; 26: 566-71.
10. Nejat M, Pickering JW, Walker RJ et al. Urinary cystatin-C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit. Care 2010; 14: R85.
11. Briguori C, Visconti G, Rivera NV et al. Cystatin-C and contrast-induced acute kidney injury. Circulation 2010; 121: 2117-22.
12. Perianayagam MC, Seabra VF, Tighiouart H et al. Serum cystatin-C for prediction of dialysis requirement or death in acute kidney injury: A comparative study. Am. J. Kidney Dis. 2009; 54: 1025-33.
13. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin-C in the rat. Scand. J. Clin. Lab. Invest. 1996; 56: 409-14.
14. Grubb AO, Cystatin C. Properties and use as diagnostic marker. Adv. Clin. Chem. 2000; 35: 63-99.
15. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin-C as a marker of GFR - history, indications, and future research. Clin. Biochem. 2005; 38: 1-8.
16. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin-C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am. J. Kidney Dis. 2002; 40: 221-6.